Back to Search
DAVID GORELICK, M.D.
M.D.
Addiction Medicine (Psychiatry & Neurology) Physician
NPI: 1659333946Individual
Specialties, Licenses & Credentials
Addiction Medicine (Psychiatry & Neurology) PhysicianPrimary
Psychiatry & Neurology — Addiction Medicine
Code: 2084A0401X
D0038998(MD)
Research & Publications (20)
Androgen receptor gene expression in the developing and adult zebrafish brain.
PMID 18816841·Dev Dyn·2008
7-preclinical
Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.
PMID 18762918·Psychopharmacology (Berl)·2008
8-other
Methods for clinical research involving cannabis administration.
PMID 16506412·Methods Mol Med·2006
6-review
Aquaporin-11: a channel protein lacking apparent transport function expressed in brain.
PMID 16650285·BMC Biochem·2006
4-observational
The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers.
PMID 16504646·Am Heart J·2006
2-rct
Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels.
PMID 16051446·Drug Alcohol Depend·2006
2-rct
Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
PMID 15953495·Biol Psychiatry·2005
4-observational
Reliability and validity of a short form of the Marijuana Craving Questionnaire.
PMID 19217724·Drug Alcohol Depend·2009
8-other
Disposition of MDMA and metabolites in human sweat following controlled MDMA administration.
PMID 19168553·Clin Chem·2009
2-rct
Interest in marijuana treatment programs among teenage smokers and nonsmokers.
PMID 19556094·J Subst Abuse Treat·2009
8-other
EEG and cerebral blood flow velocity abnormalities in chronic cocaine users.
PMID 19278131·Clin EEG Neurosci·2009
8-other
The future of endocannabinoid-oriented clinical research after CB1 antagonists.
PMID 19300982·Psychopharmacology (Berl)·2009
8-other
Why should addiction medicine be an attractive field for young physicians?
PMID 18778386·Addiction·2009
8-other
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.
PMID 18715283·Addict Biol·2009
4-observational
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
PMID 18273737·World J Biol Psychiatry·2008
6-review
Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
PMID 18520604·Ther Drug Monit·2008
2-rct
Exercise stress testing in recently abstinent chronic cocaine abusers.
PMID 18584578·Am J Drug Alcohol Abuse·2008
4-observational
Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration.
PMID 18626271·J Clin Psychopharmacol·2008
2-rct
Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) users.
PMID 18855243·Am J Drug Alcohol Abuse·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5500 NATHAN SHOCK DR
BALTIMORE, MD 21224 - Phone
- (410) 550-1478
Quick Facts
- NPI
- 1659333946
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile